Zacks Investment Research
17 Jun 2026, 22:50 UTC · 2h ago
Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
17 Jun 2026, 22:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
Adma Biologics currently holds a Zacks Rank of #5, which is the lowest possible rating indicating a 'Strong Sell'. — A Strong Sell rating from a quantitative model based on earnings estimate revisions typically signals negative short-term price momentum.
-0.60The Zacks Consensus EPS estimate for Adma Biologics has decreased by 2.38% over the past month. — Downward revisions in earnings expectations generally lead to lower valuation and reduced investor confidence.
-0.40Adma Biologics' forward P/E ratio of 10.46 is significantly discounted compared to the industry average of 21.05. — A lower P/E relative to peers can suggest the stock is undervalued, potentially attracting value investors.
+0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Full-year earnings and revenue projections for Adma Biologics are estimated to grow by 36.67% and 4.87% respectively over the prior year. — Strong projected year-over-year earnings growth is a positive fundamental driver for the stock.
+0.20Which stocks this story touches
The company has a Zacks Rank of #5 (Strong Sell), its stock is lagging the S&P 500, and EPS estimates have fallen over the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works

Zacks Investment Research
2h ago